The biomarkers that make personalisation possible
Personalised medicine is not a slogan. It is a small number of measurements that actually change what a clinician recommends.
Personalisation only means something if two people receive different advice because of a measurement. Most of the popular longevity biomarkers do not clear that bar. A few do.
Measurements that change decisions
- ApoB and Lp(a) — determine how aggressively lipids should be managed, and whether family screening is warranted
- Fasting insulin and HbA1c — show whether a nutrition change is actually working before glucose moves
- hs-CRP — reframes nagging symptoms as an inflammatory question rather than a vague one
- Vitamin D and B12 — common, cheap to correct, and frequently behind fatigue
- Thyroid profile with free hormones — explains metabolic findings that otherwise look contradictory
Measurements that mostly add noise
Single biological age scores, broad genetic risk percentages and continuously streamed metrics without a decision attached. They can be interesting. They rarely tell you what to do on Monday.
The personalisation test
For any result, ask three questions: does it change a recommendation, is it stable enough to re-measure, and is the change measurable within a realistic interval? If the answer is no to any of these, it belongs in the appendix, not the plan.
How we use them
Our panels are built so that each result maps to a decision — a supplement to stop, a training variable to add, a follow-up test to schedule, a referral to make. The report is short on purpose.